BB BIOTECH AG - PROTHENA CORP PLC ownership

PROTHENA CORP PLC's ticker is PRTA and the CUSIP is G72800108. A total of 156 filers reported holding PROTHENA CORP PLC in Q3 2017. The put-call ratio across all filers is 2.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
BB BIOTECH AG ownership history of PROTHENA CORP PLC
ValueSharesWeighting
Q1 2018$14,684,000
+11.9%
400,000
+14.3%
0.41%
+9.7%
Q4 2017$13,122,000
-42.1%
350,0000.0%0.37%
-41.1%
Q3 2017$22,670,000
+19.7%
350,0000.0%0.63%
+8.5%
Q2 2017$18,942,000
-3.0%
350,0000.0%0.58%
-9.4%
Q1 2017$19,527,000
+13.4%
350,0000.0%0.64%
+0.2%
Q4 2016$17,217,000
-18.0%
350,0000.0%0.64%
-13.6%
Q3 2016$20,990,000
+71.5%
350,0000.0%0.74%
+52.8%
Q2 2016$12,236,000
-15.1%
350,0000.0%0.48%
-15.7%
Q1 2016$14,406,000
-33.9%
350,000
+9.4%
0.57%
-6.7%
Q4 2015$21,795,000
+50.2%
320,0000.0%0.61%
+33.5%
Q3 2015$14,509,000320,0000.46%
Other shareholders
PROTHENA CORP PLC shareholders Q3 2017
NameSharesValueWeighting ↓
RA Capital Management 1,554,918$59,569,0004.27%
Cormorant Asset Management, LP 350,000$13,409,0003.08%
Redmile Group, LLC 559,611$21,439,0002.56%
Ghost Tree Capital, LLC 110,000$4,214,0002.50%
Atika Capital Management LLC 57,500$2,203,0001.88%
Palo Alto Investors LP 1,065,836$40,832,0001.69%
Perceptive Advisors 350,000$13,409,0001.41%
Orbimed Advisors 1,889,000$72,368,0000.89%
Rock Springs Capital Management LP 65,000$2,490,0000.57%
Cupps Capital Management, LLC 164,199$6,290,0000.48%
View complete list of PROTHENA CORP PLC shareholders